AU2001290902A1 - Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators - Google Patents
Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulatorsInfo
- Publication number
- AU2001290902A1 AU2001290902A1 AU2001290902A AU9090201A AU2001290902A1 AU 2001290902 A1 AU2001290902 A1 AU 2001290902A1 AU 2001290902 A AU2001290902 A AU 2001290902A AU 9090201 A AU9090201 A AU 9090201A AU 2001290902 A1 AU2001290902 A1 AU 2001290902A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- colorectal cancer
- diagnosis
- screening
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66373300A | 2000-09-15 | 2000-09-15 | |
US09/663,733 | 2000-09-15 | ||
US09/930,020 US20030077568A1 (en) | 2000-09-15 | 2001-08-14 | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
US09/930,020 | 2001-08-14 | ||
PCT/US2001/028716 WO2002021996A2 (en) | 2000-09-15 | 2001-09-14 | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001290902A1 true AU2001290902A1 (en) | 2002-03-26 |
Family
ID=27098811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001290902A Abandoned AU2001290902A1 (en) | 2000-09-15 | 2001-09-14 | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030077568A1 (en) |
EP (1) | EP1317669A4 (en) |
JP (1) | JP2004515225A (en) |
AU (1) | AU2001290902A1 (en) |
CA (1) | CA2422278A1 (en) |
MX (1) | MXPA03002323A (en) |
WO (1) | WO2002021996A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030064946A1 (en) * | 2000-08-09 | 2003-04-03 | Mcswiggen James | Method and reagent for the inhibition of calcium activated chloride channel-1 (CLCA-1) |
US20050233353A1 (en) * | 2001-02-27 | 2005-10-20 | Markowitz Sanford D | Methods and compositions for categorizing patients |
US7081516B2 (en) | 2002-08-26 | 2006-07-25 | Case Western Reserve University | Methods for categorizing patients |
US7118912B2 (en) | 2002-08-26 | 2006-10-10 | Case Western Reserve University | Methods and compositions for categorizing patients |
US20060035237A1 (en) * | 2002-08-26 | 2006-02-16 | Markowitz Sanford D | Methods and compositions for categorizing patients |
GB0208089D0 (en) * | 2002-04-09 | 2002-05-22 | Oxford Glycosciences Uk Ltd | Protein |
US20040014047A1 (en) * | 2002-07-18 | 2004-01-22 | Isis Pharmaceuticals Inc. | Antisense modulation of LIM domain kinase 1 expression |
EP1546730A2 (en) * | 2002-09-30 | 2005-06-29 | Oncotherapy Science, Inc. | Method for treating or preventing metastasis of colorectal cancers |
US7105657B2 (en) * | 2002-11-08 | 2006-09-12 | Board Of Regents Of The University Of Nebraska | Compositions and methods for inhibiting pancreatic cancer metastasis |
US20060241035A1 (en) | 2003-07-11 | 2006-10-26 | Daria Onichtchouk | Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome |
US20080199468A1 (en) * | 2004-02-24 | 2008-08-21 | Oncotherapy Science, Inc. | Method For Diagnosing Colorectal Cancers |
EP1856286A2 (en) * | 2005-02-11 | 2007-11-21 | Wisconsin Alumni Research Foundation | Mir-155 assay |
BRPI0607507A2 (en) | 2005-04-13 | 2009-09-08 | Consejo Superior Investigacion | in vitro method for the identification of cancer treatment compounds |
EP2166357A1 (en) * | 2005-08-18 | 2010-03-24 | Zadec Aps | Protein marker for diagnosing colorectal cancer |
NZ544432A (en) * | 2005-12-23 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS |
ES2491222T3 (en) | 2006-01-11 | 2014-09-05 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
EP2198306A1 (en) * | 2007-09-06 | 2010-06-23 | Case Western Reserve University | Methods for diagnosing and treating cancers |
EP2644711B1 (en) * | 2007-10-23 | 2018-07-04 | Clinical Genomics Pty Ltd | A method of diagnosing neoplasms - II |
SG10201401722XA (en) * | 2009-05-01 | 2014-08-28 | Genomic Health Inc | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer andresponse to chemotherapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5356817A (en) * | 1988-06-09 | 1994-10-18 | Yale University | Methods for detecting the onset, progression and regression of gynecologic cancers |
CA2369319A1 (en) * | 1999-03-15 | 2000-09-21 | Eos Biotechnology, Inc. | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
-
2001
- 2001-08-14 US US09/930,020 patent/US20030077568A1/en not_active Abandoned
- 2001-09-14 JP JP2002526255A patent/JP2004515225A/en not_active Withdrawn
- 2001-09-14 AU AU2001290902A patent/AU2001290902A1/en not_active Abandoned
- 2001-09-14 CA CA002422278A patent/CA2422278A1/en not_active Abandoned
- 2001-09-14 MX MXPA03002323A patent/MXPA03002323A/en unknown
- 2001-09-14 EP EP01970958A patent/EP1317669A4/en not_active Withdrawn
- 2001-09-14 WO PCT/US2001/028716 patent/WO2002021996A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2422278A1 (en) | 2002-03-21 |
WO2002021996A3 (en) | 2003-02-06 |
MXPA03002323A (en) | 2003-08-01 |
WO2002021996A2 (en) | 2002-03-21 |
EP1317669A4 (en) | 2005-04-06 |
JP2004515225A (en) | 2004-05-27 |
US20030077568A1 (en) | 2003-04-24 |
EP1317669A2 (en) | 2003-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002252144A1 (en) | Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer | |
AU2002215345A1 (en) | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer | |
AU2002309583A1 (en) | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer | |
AU2002347428A1 (en) | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer | |
AU2002245317A1 (en) | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer | |
AU2002330039A1 (en) | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer | |
AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
AU2001290902A1 (en) | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators | |
AU2002257004A1 (en) | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | |
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2002249871A1 (en) | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
AU2002339865A1 (en) | Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU3491001A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
AU3755300A (en) | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU3752700A (en) | Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators | |
AU6902200A (en) | Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002364708A1 (en) | Novel compositions and methods for cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002357734A1 (en) | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer | |
AU2002337943A1 (en) | Novel compositions and methods for cancer |